Improving Medication Use for Older Adults: An Integrated Research Agenda

Annals of Internal Medicine

Volumn 139, Issue 5 II, 2003, Pages 425-429

  Murray, Michael D ^a,b   Callahan, Christopher M ^a  

^a INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

AGING; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FATALITY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG USE; HEALTH CARE; HEALTH CARE POLICY; HUMAN; IATROGENIC DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICARE; PHARMACOEPIDEMIOLOGY; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; AGED; CLINICAL TRIAL; DRUG THERAPY; DRUG UTILIZATION; ECONOMICS; POLICY; POLYPHARMACY; RESEARCH; REVIEW; STANDARD;

AGED; CLINICAL TRIALS; DRUG THERAPY; DRUG UTILIZATION; HUMANS; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PUBLIC POLICY; RESEARCH;

EID: 0141608150     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-5_part_2-200309021-00009     Document Type: Conference Paper

References (52)

1. Ihara E, Summer L, Shirey L. Prescription drugs: a vital component of health care. In: Challenges for the 21st Century: Chronic and Disabling Conditions. Washington, DC: Center on an Aging Society, Georgetown University; 2002: 1-5. Accessed at http://ihcrp.georgetown.edu/agingsociety/pdfs/rxdrugs .pdf on 20 June 2003.
2. National Association of Chain Drug Stores. Industry Facts at-a-Glance. Industry statistics. Accessed at www.nacds.org/wmspage.cfm?parm1 = 507 on 20 June 2003.
3. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162: 2269-76. [PMID: 12418941]
4. Bodkin JA, Amsterdam JD. Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am J Psychiatry. 2002;159:1869-75. [PMID: 12411221]
5. PHRMA Research and Development. Dramatic growth of research and development. Pharmaceutical Manufacturers Association. Accessed at www.phrma.org/publications/publications/profile02/2003%20CHAPTER%202.pdf on 20 June 2003.
6. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-16. [PMID: 12622580]
7. Zimmer AW, Calkins E, Hadley E, Ostfeld AM, Kaye JM, Kaye D. Conducting clinical research in geriatric populations. Ann Intern Med. 1985;103: 276-83. [PMID: 4014906]
8. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287:2215-20. [PMID: 11980521]
9. Perkins SM, Tu W, Underhill MG, Zhou XH, Murray MD. The use of propensity scores in pharmacoepidemiologic research. Pharmacoepidemiol Drug Safety. 2000;9:93-101.
10. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-63. [PMID: 9382394]
11. Strom BL, ed. Pharmacoepidemiology. 3rd ed. New York: J Wiley; 2000.
12. Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med. 2000;160:2717-28. [PMID: 11025781]
13. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956-66. [PMID: 2024864]
14. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109:87-94. [PMID: 10967148]
15. Darnell JC, Murray MD, Martz BL, Weinberger M. Medication use, by ambulatory elderly. An in-home survey. J Am Geriatr Soc. 1986;34:1-4. [PMID: 3941238]
16. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158:2200-11. [PMID: 9818800]
17. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-97. [PMID: 12479763]
18. Kass-Bartelmes B, Bosco L. Prescription drug therapies: Reducing costs and improving outcomes. In: Research in Action. Rockville, MD: Agency for Healthcare Research and Quality; 2002. AHRQ #8, 1-11. Accessed at www.ahrq.gov/qual/rxthetapies/rxria.pdf on 20 June 2003.
19. Hwang W, Weller W, Ireys H, Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood). 2001;20:267-78. [PMID: 11816667]
20. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331:650-5. [PMID: 8052275]
21. Kreling D, Mott D, Wiederholt J. Prescription Drug Trends: A Chartbook. Menlo Park, CA: The Henry J. Kaiser Family Foundation; 2000:1-95.
22. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16: 793-9. [PMID: 11903757]
23. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-9. [PMID: 11242426]
24. Knickman JR, Snell EK. The 2030 problem: caring for aging baby boomers. Health Serv Res. 2002;37:849-84. [PMID: 12236388]
25. Soumerai SB, Adams AS, Ross-Degnan D. Medicare prescription coverage and congressional gridlock [Editorial]. J Gen Intern Med. 2001;16:864-6. [PMID: 11903767]
26. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-63. [PMID: 9869666]
27. Tu K, Mamdani MM, Tu JV. Hypertension guidelines in elderly patients: is anybody listening? Am J Med. 2002;113:52-8. [PMID: 12116987]
28. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157:1531-6. [PMID: 9236554]
29. Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001;286: 2823-9. [PMID: 11735757]
30. McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term case setting. Arch Intern Med. 2001;161:2458-63. [PMID: 11700158]
31. Lemaitre RN, Psaty BM, Heckbert SR, Kronmal RA, Newman AB, Burke GL. Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. Arch Intern Med. 2002;162:1395-400. [PMID: 12076239]
32. Gattis WA, Larsen RL, Hasselblad V, Bart BA, O'Connor CM. Is optimal angiotensin-convetting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J. 1998;136:43-8. [PMID: 9665217]
33. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135:703-10. [PMID: 11601953]
34. Murray MD. Information technology: the infrastructure for improvements to the medication-use process. Am J Health Syst Pharm. 2000;57:565-71. [PMID: 10754766]
35. Avorn J. Improving drug use in elderly patients: getting to the next level [Editorial]. JAMA. 2001;286:2866-8. [PMID: 11735764]
36. Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription [Editorial]. Arch Intern Med. 2002;162: 1670-2. [PMID: 12153368]
37. Teich JM, Merchia PR, Schmiz JL, Kuperman GJ, Spurr CD, Bates DW. Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000;160:2741-7. [PMID: 11025783]
38. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109:87-94. [PMID: 10967148]
39. Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA. 2001; 286:2839-44. [PMID: 11735759]
40. Rollman BL, Gilbert T, Lowe HJ, Kapoor WN, Schulberg HC. The electronic medical record: its role in disseminating depression guidelines in primary care practice. Int J Psychiatry Med. 1999;29:267-86. [PMID: 10642902]
41. Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288:1403-9. [PMID: 12234237]
42. Murray MD, Darnell J, Weinberger M, Martz BL. Factors contributing to medication noncompliance in elderly public housing tenants. Drug Intell Clin Pharm. 1986;20:146-52. [PMID: 3948692]
43. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337-44. [PMID: 11790213]
44. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002;288:2432-40. [PMID: 12435256]
45. Bell RA, Kravitz RL, Thom D, Krupat E, Azari R. Unmet expectations for care and the patient-physician relationship. J Gen Intern Med. 2002;17:817-24. [PMID: 12406352]
46. Bikowski RM, Ripsin CM, Lorraine VL. Physician-patient congruence regarding medication regimens. J Am Geriatr Soc. 2001;49:1353-7. [PMID: 11890495]
47. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-79. [PMID: 12472329]
48. Morrow D, Leirer V, Altieri P, Tanke E. Elders' schema for taking medication: implications for instruction design. J Gerontol. 1991;46:P378-85. [PMID: 1940095]
49. Grumbach K, Bodenheimer T. A primary care home for Americans: putting the house in order. JAMA. 2002;288:889-93. [PMID: 12186609]
50. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775-9. [PMID: 12365965]
51. Phelan EA, Williams B, Leveille S, Snyder S, Wagner EH, LoGerfo JP. Outcomes of a community-based dissemination of the health enhancement program. J Am Geriatr Soc. 2002;50:1519-24. [PMID: 12383149]
52. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159:1939-45. [PMID: 10493325]